Literature DB >> 24273467

Role of apoptosis in colon cancer biology, therapy, and prevention.

Lin Zhang1, Jian Yu.   

Abstract

Deregulation of apoptosis is a hallmark of human cancer and contributes to therapeutic resistance. Recent advances in cancer genomics reveal a myriad of alterations in key pathways that directly or indirectly increase tumor cell survival. This review will outline the pathways of apoptosis in mammalian cells, and highlight the common alterations of apoptosis regulators found in colon cancer, the role of apoptosis and underlying mechanisms in colon cancer treatment and prevention, including recent advances on investigational agents, such as kinase inhibitors, proteasome inhibitors, HSP90 inhibitors, BH3 mimetics, TRAIL, and IAP antagonists. Topics will also include novel concepts, as well as opportunities and challenges for drug discovery and combination therapy by exploring cancer-specific genetic defects, and therefore selective induction of apoptosis in cancer cells. Although the emphasis is on colon cancer, the main theme and many of the aspects are applicable to other solid tumors.

Entities:  

Keywords:  BH3 mimetics; BH3-only protein; Bcl-2 family; EGFR; Hsp90 inhibitors; IAPs; K-RAS; NSAIDs; PI3K; SMAC mimetics; TRAIL; apoptosis; autophagy; b-Raf; c-Myc; colon cancer; death receptor; mitochondria; necrosis; protesome inhibitors; regorafinib; sorafenib; synthetic lethality; targeted therapies; vemurafenib

Year:  2013        PMID: 24273467      PMCID: PMC3836193          DOI: 10.1007/s11888-013-0188-z

Source DB:  PubMed          Journal:  Curr Colorectal Cancer Rep        ISSN: 1556-3790


  99 in total

1.  PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.

Authors:  Crissy Dudgeon; Peng Wang; Xiameng Sun; Rui Peng; Quanhong Sun; Jian Yu; Lin Zhang
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

Review 2.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

Authors:  R A Gupta; R N Dubois
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 3.  Pathologies associated with the p53 response.

Authors:  Andrei V Gudkov; Elena A Komarova
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-07       Impact factor: 10.005

4.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

Review 5.  Integrating genetic approaches into the discovery of anticancer drugs.

Authors:  L H Hartwell; P Szankasi; C J Roberts; A W Murray; S H Friend
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

6.  Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.

Authors:  Maryla Krajewska; Hoguen Kim; Chul Kim; Haeyoun Kang; Kate Welsh; Shu-Ichi Matsuzawa; Michelle Tsukamoto; Ronald G Thomas; Nuria Assa-Munt; Zhe Piao; Koichi Suzuki; Manuel Perucho; Stan Krajewski; John C Reed
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

Review 7.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

8.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

Authors:  Ji Luo; Michael J Emanuele; Danan Li; Chad J Creighton; Michael R Schlabach; Thomas F Westbrook; Kwok-Kin Wong; Stephen J Elledge
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

10.  Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors.

Authors:  A V Vaseva; A R Yallowitz; N D Marchenko; S Xu; U M Moll
Journal:  Cell Death Dis       Date:  2011-05-12       Impact factor: 8.469

View more
  36 in total

1.  BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5.

Authors:  Xiao Tan; Jingshan Tong; Yi-Jun Wang; Rochelle Fletcher; Robert E Schoen; Jian Yu; Liangfang Shen; Lin Zhang
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

2.  Oxidative stress, apoptosis, and cell cycle arrest are induced in primary fetal alveolar type II epithelial cells exposed to fine particulate matter from cooking oil fumes.

Authors:  Ying Liu; Yan-Yan Chen; Ji-Yu Cao; Fang-Biao Tao; Xiao-Xia Zhu; Ci-Jiang Yao; Dao-Jun Chen; Zhen Che; Qi-Hong Zhao; Long-Ping Wen
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-31       Impact factor: 4.223

Review 3.  Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma.

Authors:  Paramita Mandal
Journal:  Inflammopharmacology       Date:  2017-12-30       Impact factor: 4.473

4.  Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer.

Authors:  Hisato Kawakami; Shengbing Huang; Krishnendu Pal; Shamit K Dutta; Debabrata Mukhopadhyay; Frank A Sinicrope
Journal:  Mol Cancer Ther       Date:  2016-10-07       Impact factor: 6.261

5.  In vivo regulation of colonic cell proliferation, differentiation, apoptosis, and P27Kip1 by dietary fish oil and butyrate in rats.

Authors:  Mee Young Hong; Nancy D Turner; Mary E Murphy; Raymond J Carroll; Robert S Chapkin; Joanne R Lupton
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-31

6.  1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane potentiates in vitro and in vivo antitumor effects of irinotecan on human colorectal cancer cells.

Authors:  Po-Sheng Yang; Jane-Jen Wang; Yea-Hwey Wang; Woan-Ching Jan; Shih-Ping Cheng; Yi-Chiung Hsu
Journal:  Oncol Lett       Date:  2016-04-07       Impact factor: 2.967

Review 7.  Immunogenic cell death in colon cancer prevention and therapy.

Authors:  Hang Ruan; Brian J Leibowitz; Lin Zhang; Jian Yu
Journal:  Mol Carcinog       Date:  2020-03-25       Impact factor: 4.784

Review 8.  Pathophysiological mechanisms of death resistance in colorectal carcinoma.

Authors:  Ching-Ying Huang; Linda Chia-Hui Yu
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  The pro-apoptotic role of the regulatory feedback loop between miR-124 and PKM1/HNF4α in colorectal cancer cells.

Authors:  Yan Sun; Xiaoping Zhao; Man Luo; Yuhong Zhou; Weiying Ren; Kefen Wu; Xi Li; Jiping Shen; Yu Hu
Journal:  Int J Mol Sci       Date:  2014-03-11       Impact factor: 5.923

10.  mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation.

Authors:  K He; X Zheng; M Li; L Zhang; J Yu
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.